Finance

Lists
CHRS:NASDAQ
Coherus Oncology Inc
US$ १.०७
०.००%
(०.००) 1D
US$ १.०९
+१.८७% (+०.०२०)
After hours
Closed: अक्टोबर ९, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHRS...
Open
US$ १.०६
High
US$ १.१२
Low
US$ १.०५
Mkt. cap
१६.५३ करोड
Avg. vol.
१३.५४ लाख
Volume
१६.९७ लाख
52-wk high
US$ २.६२
52-wk low
US$ ०.९७
EPS
-US$ १.०३
Beta
०.९८
Shares outstanding
१५.४५ करोड
No. of employees
१४४
Open
US$ १.०६
High
US$ १.१२
Low
US$ १.०५
Mkt. cap
१६.५३ करोड
Avg. vol.
१३.५४ लाख
Volume
१६.९७ लाख
52-wk high
US$ २.६२
52-wk low
US$ ०.९७
EPS
-US$ १.०३
Beta
०.९८
Shares outstanding
१५.४५ करोड
No. of employees
१४४
News stories
From web sources and news partners
About Coherus Oncology Inc
CEODennis Lanfear
Employees१४४
Founded२०१०
HeadquartersRedwood City, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to CHRS in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CHRS in the last 3 months.
Highest
Current US$ १.०७
US$ १०.०० (+८३४.५८%)
Average
US$ ७.७५ (+६२४.३०%)
Lowest
US$ ४.०० (+२७३.८३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
US$ ७.००
+५५४.२%
09/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ४.००
+२७३.८%
08/06/2026
Paul Jeng
Guggenheim
Buy
Maintained
US$ १०.००
+८३४.६%
08/06/2026
Jay Olson
Oppenheimer
Buy
Maintained
US$ १०.००
+८३४.६%
08/06/2026
Michael Nedelcovych
TD Cowen
Buy
Maintained
-
-
05/28/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.१६ करोड
१.२७ करोड
१.२३ करोड
१.४३ करोड
Cost of goods sold
३७.२१ लाख
४०.४५ लाख
३८.१४ लाख
४२.३७ लाख
Cost of revenue
३७.२१ लाख
४०.४५ लाख
३८.१४ लाख
४२.३७ लाख
Research and development expenses
२.७३ करोड
३.१० करोड
२.१५ करोड
२.१४ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.२८ करोड
२.१० करोड
२.३१ करोड
२.१० करोड
Operating expense
५.०१ करोड
५.२० करोड
४.४६ करोड
४.२४ करोड
Total operating expenses
५.३८ करोड
५.६० करोड
४.८५ करोड
४.६६ करोड
Operating income
-४.२२ करोड
-४.३३ करोड
-३.६२ करोड
-३.२३ करोड
Other non operating income
२१.४१ लाख
-५२.१८ लाख
१४.०२ लाख
१३.०७ लाख
EBT including unusual items
-४.४५ करोड
-४.६३ करोड
-३.६९ करोड
-३.३३ करोड
EBT excluding unusual items
-४.२४ करोड
-४.३७ करोड
-३.६९ करोड
-३.३३ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३.५५ करोड
-३.७६ करोड
-३.८३ करोड
-२.०६ करोड
Net profit margin
-३०७.०७%
-२९५.२९%
-३११.३५%
-१४४.२०%
Earnings per share
-०.३३
-०.३४
-०.२५
-०.१९
Interest and investment income
-
७०.०० लाख
-
-
Interest expense
-२३.२५ लाख
-२२.४९ लाख
-२१.८६ लाख
-२३.२३ लाख
Net interest expenses
-२३.२५ लाख
४७.५१ लाख
-२१.८६ लाख
-२३.२३ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-४.१३ करोड
-४.२४ करोड
-३.५३ करोड
-३.१५ करोड
Gain or loss from assets sale
-
-३३.८३ करोड
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू